Q&A: Bristol Myers’ tech chief on the promises and perils of AI bio

For AI-fo­cused star­tups seek­ing out phar­ma deals, they have to go through peo­ple like Greg Mey­ers, the chief dig­i­tal and tech­nol­o­gy of­fi­cer at Bris­tol My­ers …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.